Title: Peri implantitis: The implant era’s greatest challenge and the road ahead
Abstract:
The widespread adoption of dental implants has transformed the rehabilitation of partially and completely edentulous patients, offering predictable functional and esthetic outcomes with high long-term survival rates. However, the increasing prevalence of peri-implant diseases, particularly peri-implantitis, has emerged as one of the most significant biological complications threatening implant longevity. Characterized by inflammation of the peri-implant tissues accompanied by progressive bone loss, peri-implantitis presents a complex clinical challenge due to its multifactorial etiology, unpredictable progression, and variable treatment outcomes.
Current evidence indicates that peri-implantitis results from the interplay of microbial biofilms, host immune response, implant surface characteristics, prosthetic design, systemic conditions such as diabetes, smoking, previous history of periodontitis, occlusal overload, and inadequate maintenance. Early diagnosis remains critical, yet standardized diagnostic criteria and universally accepted treatment protocols continue to evolve. Conventional therapeutic approaches—including mechanical debridement, antiseptic and antibiotic therapy, implant surface decontamination, laser-assisted treatment, regenerative procedures, and resective surgery—have demonstrated varying degrees of success, highlighting the need for more predictable and personalized management strategies.
The future of peri-implantitis management lies in precision dentistry, integrating advances in artificial intelligence (AI), digital diagnostics, salivary biomarkers, microbiome analysis, laser technology, photodynamic therapy, and regenerative biomaterials. AI-assisted radiographic interpretation and predictive analytics have the potential to identify high-risk patients before significant tissue destruction occurs, while salivary diagnostics may enable chairside detection of inflammatory biomarkers for early intervention. Emerging implant surface modifications with antimicrobial and bioactive coatings, nanotechnology-based drug delivery systems, probiotics, host modulation therapy, and tissue engineering approaches offer promising avenues to prevent biofilm formation and enhance peri-implant tissue regeneration. Furthermore, digital workflows and personalized maintenance protocols are expected to improve long-term implant success by tailoring preventive strategies to individual patient risk profiles.
This presentation provides a comprehensive overview of the epidemiology, pathogenesis, diagnosis, risk assessment, and contemporary treatment modalities for peri-implantitis while critically examining the limitations of current therapies. It further explores the transformative role of emerging technologies and interdisciplinary research in reshaping the future of implant care. Emphasis will be placed on prevention, early detection, minimally invasive intervention, and precision-based management as the cornerstones of sustainable implant therapy.
As implant dentistry continues to evolve, overcoming peri-implantitis will require a paradigm shift from reactive treatment to proactive prevention supported by innovation, evidence-based clinical protocols, and patient-centered care. Addressing this challenge effectively will be fundamental to ensuring the long-term success and sustainability of implant therapy in the decades ahead.
